Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Smith & Nephew PLC Board/Management Information 2016

Apr 26, 2016

4588_dirs_2016-04-26_38ebf9f0-417d-4e8d-920c-19782d65bac2.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4249W

Smith & Nephew Plc

26 April 2016

26 April 2016

Smith & Nephew plc

DIRECTOR DECLARATION

In accordance with Listing Rule 9.6.14 R the Company announces that Joseph Papa, Non-Executive Director, will be joining the Board of Valeant Pharmaceuticals International, Inc (Valeant) as its Chairman and Chief Executive in early May 2016.  Valeant is listed on both the New York and Toronto Stock Exchanges.  In addition, Mr Papa has resigned as Chairman and Chief Executive Officer of Perrigo Company plc with effect from 25 April 2016. 

Contact:

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel:  +44 (0)20 7401 7646

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDNPGUGWCUPQGQQ